Intimation regarding the appointment of Additional director who will the regularised in the ensuing EGM which is going to be held on 22 july,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed BSE about the appointment of an Additional Director on its board. The appointment will be placed before shareholders for regularisation at the upcoming Extraordinary General Meeting (EGM) scheduled on July 22, 2025. No additional details about the appointee's name, background, or role have been disclosed in the filing. This is a standard corporate disclosure required under SEBI LODR regulations whenever a board seat is filled during a non-AGM period.
Routine governance disclosure with no immediate material impact on shareholders. Investors should watch the EGM notice and outcome for details on the new director's identity and background to assess any strategic shift.